To date physical overloads, tension of life rhythm, emotional stress, etc., can not be excluded from the sphere of the human professional activity. It quite often results in the partial loss of their working efficiency, the organism overexcitation, worsening of sleep and the general state and, therefore, in extended psychological and neurotic disorders [1] . Top records sport is not exception -solving the problem of treatment and rehabilitation of sportsmen with overload and the overtraining syndrome continues to remain one of key tasks in sport medicine [2, 10] .
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Under present-day conditions the training process of most of professional sportsmen takes place in the mode of increased tension and is characterized by continuous physical loads, which results in increasing the frequency of psychological, stress and psychotraumatic situations. In the period of intensive training there is also weakening of the immune system and the organism exhaustion being often the cause of change of its immunological reactivity. All mentioned above results in worsening of the sportsmen effectiveness.
In literature sources there is the information that in intensive sports activities the immune system is subjected, on the one hand, to training impact of physical and emotional load that extends its functionality, and on the other hand -to distress effect of extreme irritants occurring at the excessive loading [7] .
To prevent these phenomena it is reasonable to use medicines, which are able to strengthen the body's immune system and reduce the irritating and psychoemotional loading without a doping effect.
It should be noted that medicines of the natural origin, in particular on the basis of beekeeping products [5] , as well as herbal medicines (HM), are widely used lately in pharmaceutical practice; it is conditioned by their relative availability, efficiency and harmlessness, and in some cases by their competitiveness relative to their synthetic analogues.
Besides, apiproducts and components of medicinal plant raw material (MPR) are derivatives of the body natural metabolites by their chemical structure; by low toxicity and the minimal number of complications in therapeutic doses they show numerous pharmacological properties [5] .
Therefore, along with hygienical and technological measures one of urgent tasks of sport medicine is the search, development and manufacturing application of natural medicines, which are able to increase the body's resistance to extreme influences and psychological disorders.
The studies on development of the composition and technology of medicines for application in sport medicine, mainly on the basis of the standardized substances of beekeeping products are carried out. One of these medicines is the original medicine in the form of capsules under the conditional name "Apised" developed on the basis of natural powder-like honey (NPH) and the medicinal plant raw material (the herb of garden balm, the cones of hop, the inflorescences of spike lavender). It is recommended to application with the purpose of rehabilitation acceleration of the body's functions of sportsmen worsened as the result of overstrain and overtraining, and also as the additional source of vitamins, organic and mineral acids, essential oils, alkaloids, flavonoids, phenolic compounds, antioxidants, etc. [6, 8] .
The choice of capsules as a dosage form with oral application, in the first place, is related to such advantages as accuracy of dose, comfort in application and storage, portability, etc., as well as high bioavailability of active pharmaceutical ingredients (APhI), which are the components of the medicine developed.
The aim of this work is to substantiate the qualitative composition and quantitative content of excipients; it will allow to provide optimal pharmaceutical and technological properties of the mass for capsulation when producing "Apised" capsules developed under conditions of pharmacy and industrial production.
Materials and Methods
The objects of the research were the following samples of APhI of "Apised" capsules: the herb of garden balm -Herba Melissa officinalis L. by freeze drying under conditions of "Biolik" JSС (Kharkiv) using "Virtis" production equipment (USA) [6] .
Our research was carried out on the basis that one capsule would contain 0.225 g of active substances [6] . Talc, aerosil of A-380 grade (the State Standard 14922-77), starch (the State Standard 7699-78), calcium stearate (the Ukrainian specification 22942814.003-2000), Plasdone K29/32, Plasdone S629 and polyvinylpyrrolidone (PVP) [9, [11] [12] [13] [14] [15] [16] [17] [18] [19] were used as excipients.
The flowability was studied for APhI, their mixture and the masses for capsulation obtained, as well the bulk volume, ability to settle, density of bulk and settled product were determined according to the procedure of SPhU (SPhU 1 th ed., art. 2.9.15, art. 2.9.16) [3, 4] . Besides, the value of the angle of natural slip was measured by means of a goniometer.
When studying the moisture absorption APhI, their mixture and masses for capsulation were introduced into the preliminary weighted weighing bottles with the diameter of 29±0.5 mm and the height of 35±0.5 mm, the weighing bottles were placed into the desiccator with the diameter of 140 mm; the permanent relative air humidity at the level of 100% created with purified water was supported in the desiccator at the temperature of 20°С. In a certain period of time the samples of the substances studied were taken from weighing bottles, and the moisture content was determined in them by means of a "Sartorius"humidity analyser of МА-150 grade produced by "Sartorius" AG group company, Germany.
Results and Discussion
The results of studying the pharmaceutical and technological properties of APhI and their mixtures (flowability, angle of natural slip, bulk volume, ability to settle, density of bulk product) indicate that it is impossible to obtain the mass for capsulation with satisfactory values of flowability and ability to settle without additional introduction of excipients (Tab. 1).
Therefore, to improve these parameters such antifriction substances as talc, starch, Plasdone K29/32, as Table 1 The pharmaceutical and technological parameters of the active substances of the "Apised" capsules and their mixture (n = 5, P = 95%) well as calcium stearate and aerosil in the amount of 0.5-2.0% were added to the mixture of active substances.
The results obtained are given in Tab. 2 and Fig. 1 . The results of the pharmaceutical and technological research show that addition of aerosil or its mixture with calcium stearate (3:1) in the amount of 2% is the most expedient for improvement of flowability of the mixture of active substances. Addition of calcium stearate or its mixture with Plasdone K29/32 also increases flowability of the mass for capsulation, however, less effectively. Further increase of the content of antifriction substances is not expedient as the parameters of flowability do not significantly improve. It should be noted that introduction of calcium stearate also allows to avoid adhesion of a powder-like mixture to the capsule-filling machine in the process of capsulation.
The results of the experimental research indicate that in spite of improvement of flowability when adding the excipients to the mixture of APhI, ability to settle of the masses for capsulation obtained continues to be unsatisfactory large. Moreover, stratification of the mixture is fixed visually, it is confirmed by the considerable differences of pharmaceutical and technological parameters of APhI. Therefore, in order to prevent occurrence of this phenomenon we have suggested to carry out pregranulation of the mixture of active substances. Thus, starch (in the form of 5% solution) and PVP, Plasdone K29/32 and Plasdone S629 in different amounts were used as wetting agents. The results of the flowability research of the granular masses for capsulation obtained are given in Fig. 2 , they indicate that the best values of flowability were obtained when using Plasdone K29/32 as a wetting agent in the amount of 5%. Thus, ability to settle decrease and achieve acceptable values. It is also necessary to note that the disintegration time of granules does not exceed acceptable limits.
The use of 5% starch solution as a wetting agent results in adherence of the granulate obtained, and it makes impossible its application for manufacturing of "Apised" capsules developed.
The next stage of our research was the choice of the optimal order of mixing and granulation of active and excipients. Three variants of the procedure of obtaining the mass for capsulation were studied: 1) 5% solution of Plasdone K29/32 was added to the mixture of APhI and antifriction substances (aerosil or its mixture with calcium stearate (3:1)), and granulation was carried out;
2) 5% solution of Plasdone K29/32 was added to the mixture of MPR and antifriction substances (aerosil or its mixture with calcium stearate (3:1)), and granula- Table 2 The pharmaceutical and technological parameters of the masses for capsulation of "Apised" capsules developed (n = 5, P = 95%) tion was carried out, then NPH was added to the granulate obtained; 3) 5% solution of Plasdone K29/32 was added to the mixture of MPR, and granulation was carried out, then NPH and antifriction substances (aerosil or its mixture with calcium stearate (3:1)) were added to the granulate obtained.
It has been found that optimal pharmaceutical and technological parameters were obtained under conditions of application of the third variant of the procedure of preparing the mass for capsulation. It is recommended to use in future when developing the technology of "Apised" capsules.
The results of the experiment has also shown that the mixture of APhI has unsatisfactory parameters of moisture absorption (Fig. 3) . Therefore, it is necessary to introduce a humidity regulator to the composition of the mass for capsulation. One of the most used humidity regulators is aerosil. We suggested it for introduction to the composition of the mass for capsulation to improve its flowability at the previous stage of our research. In this connection, moisture absorption of the masses obtained for capsulation was also studied. The results obtained indicate that there is no need of further addition of humidity regulators (Fig. 3) .
Thus, the complex of pharmaceutical and technological research conducted has allowed to substantiate the qualitative composition and quantitative content of excipients in the composition of the mass for capsulation under the conditions of pharmacy and industrial production of "Apised" capsules developed (aerosil -1.5%, calcium stearate -0.5%, Plasdone K29/32 -5% or aerosil -2%, Plasdone K29/32 -5%), as well as the procedure of obtaining the mass for capsulation. CONCLUSIONS 1. The complex of the pharmaceutical and technological research has been carried out in order to substantiate the qualitative composition and quantitative content of excipients under the conditions of pharmacy and industrial production of "Apised" capsules developed.
2. The expediency of introduction of antifriction substances into the composition of the mass for capsulation has been determined, and their optimal amount in the process of production of "Apised" capsules: aerosil -1.5%, calcium stearate -0.5% or aerosil -2% has been experimentally substantiated.
3. The necessity of pre-granulation of the mass for capsulation has been shown, the choice of a wetting agent, its amount and the procedure of obtaining the granular mass for capsulation in the course of production of the medicine developed have been substantiated. 
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